ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
5.55
-0.83 (-13.01%)
Aug 20, 2026, 3:37 PM EDT - Market open
ARS Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -215.43 | -171.3 | 8 | -54.37 | -34.68 | -20.24 |
Depreciation & Amortization | 1.62 | 1.37 | 0.08 | 0.07 | 0.03 | 0.21 |
Asset Writedown & Restructuring Costs | - | - | - | - | 1.06 | - |
Loss (Gain) From Sale of Investments | -3.74 | -5.52 | -7.25 | -6.85 | 0.29 | - |
Stock-Based Compensation | 31.24 | 22.1 | 14.53 | 9.24 | 5.84 | 2.83 |
Other Operating Activities | 2.58 | 2.5 | - | - | 0.14 | -0 |
Change in Accounts Receivable | -24.3 | -17.21 | -8.18 | - | - | - |
Change in Inventory | -9.04 | -21.99 | -5.95 | - | - | - |
Change in Accounts Payable | 22.74 | 18.88 | 16.41 | -2.78 | -10.29 | 0.97 |
Change in Unearned Revenue | -0.2 | -0.35 | 2.09 | -3.14 | -1.32 | -2.51 |
Change in Other Net Operating Assets | -1.89 | 0.66 | -6.19 | -1.45 | -1.15 | 1.18 |
Operating Cash Flow | -196.41 | -170.87 | 13.55 | -59.27 | -40.08 | -17.56 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.2 | -0.34 | -0.56 | -0.18 | -0.2 | -0.06 |
Investment in Securities | 56.55 | 64.97 | -98.04 | -87.01 | - | - |
Other Investing Activities | -7.86 | -7.86 | -7.5 | - | - | - |
Investing Cash Flow | 48.5 | 56.77 | -106.1 | -87.18 | -0.2 | -0.06 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 96.26 | - | - | - | - |
Long-Term Debt Repaid | - | - | - | - | -8.68 | -1.82 |
Net Debt Issued (Repaid) | 96.26 | 96.26 | - | - | -8.68 | -1.82 |
Issuance of Common Stock | 3.11 | 5.68 | 3.02 | 6.9 | 0.57 | 0.17 |
Other Financing Activities | 5.17 | 2.66 | 69.38 | - | 198.84 | - |
Financing Cash Flow | 104.53 | 104.6 | 72.4 | 6.9 | 190.73 | 53.16 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -43.38 | -9.5 | -20.15 | -139.55 | 150.46 | 35.54 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -196.6 | -171.21 | 12.99 | -59.44 | -40.28 | -17.62 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -168.14% | -203.14% | 14.57% | -198136.67% | -3060.56% | -319.94% |
Free Cash Flow Per Share | -1.98 | -1.74 | 0.13 | -0.62 | -1.01 | -0.61 |
Levered Free Cash Flow | -117.7 | -94.59 | 16.5 | -36.17 | -17.86 | -9.57 |
Unlevered Free Cash Flow | -113 | -92.96 | 16.5 | -36.17 | -17.86 | -9.07 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 7.07 | 2.45 | - | - | 0.37 | 0.58 |
Change in Working Capital | -12.68 | -20 | -1.81 | -7.36 | -12.75 | -0.36 |